440 Preclinical safety assessment for specificity of biotherapeutics using the membrane proteome array

• Tabb Sullivan,
• Carmen Navia,
• Rachel Fong,
• Benjamin Doranz,
• Rona Wilf

Affiliations

Tabb Sullivan

Integral Molecular, Philadelphia, PA, USA

Carmen Navia

Integral Molecular, Philadelphia, PA, USA

Rachel Fong

Integral Molecular, Philadelphia, PA, USA

Benjamin Doranz

Integral Molecular, Philadelphia, PA, USA

Rona Wilf

Integral Molecular, Philadelphia, PA, USA